Literature DB >> 10202958

Liquid chromatographic studies with immobilized neuronal nicotinic acetylcholine receptor stationary phases: effects of receptor subtypes, pH and ionic strength on drug-receptor interactions.

I W Wainer1, Y Zhang, Y Xiao, K J Kellar.   

Abstract

Nicotinic acetylcholine receptor (nAChR) alpha3-subunits, beta4-subunits, alpha3/beta4-subunit combination and alpha4/beta2-subunit combination were immobilized on chromatographic stationary phases and the binding affinities of the different nAChR subtypes were chromatographically evaluated. The observed relative binding affinities of epibatidine were alpha4/beta2>alpha3/beta4 and epibatidine did not bind at alpha3-subunits and beta4-subunits. No significant difference in binding affinities was observed on the alpha4/beta2 nAChRs immobilized in immobilized artificial membrane (IAM) particles and those sterically immobilized on Superdex 200 beads. The effects of mobile phase pH and ionic strength on the binding affinities of the alpha3/beta4 nAChRs support were also investigated. The results are consistent with the proposed ligand-nAChR binding model in which a cationic center exists at the binding site.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10202958     DOI: 10.1016/s0378-4347(98)00579-9

Source DB:  PubMed          Journal:  J Chromatogr B Biomed Sci Appl        ISSN: 1387-2273


  9 in total

1.  Multiple receptor liquid chromatographic stationary phases: the co-immobilization of nicotinic receptors, gamma-amino-butyric acid receptors, and N-methyl D-aspartate receptors.

Authors:  Ruin Moaddel; Jean-François Cloix; Gözen Ertem; Irving W Wainer
Journal:  Pharm Res       Date:  2002-01       Impact factor: 4.200

2.  Screening of tobacco smoke condensate for nicotinic acetylcholine receptor ligands using cellular membrane affinity chromatography columns and missing peak chromatography.

Authors:  Alexandre Maciuk; Ruin Moaddel; Jun Haginaka; Irving W Wainer
Journal:  J Pharm Biomed Anal       Date:  2007-11-26       Impact factor: 3.935

3.  Identification of metabolites of propyrisulfuron in rats.

Authors:  Tomoyuki Takaku; Kazuki Mikata; Hirohisa Nagahori; Yoshihisa Sogame
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2014-02-22       Impact factor: 3.205

Review 4.  Multiple protein stationary phases: a review.

Authors:  N S Singh; K-L Habicht; K S S Dossou; R Shimmo; I W Wainer; R Moaddel
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2014-04-13       Impact factor: 3.205

Review 5.  High performance affinity chromatography and related separation methods for the analysis of biological and pharmaceutical agents.

Authors:  Chenhua Zhang; Elliott Rodriguez; Cong Bi; Xiwei Zheng; Doddavenkatana Suresh; Kyungah Suh; Zhao Li; Fawzi Elsebaei; David S Hage
Journal:  Analyst       Date:  2018-01-15       Impact factor: 4.616

Review 6.  Affinity chromatography: A review of trends and developments over the past 50 years.

Authors:  Elliott L Rodriguez; Saumen Poddar; Sazia Iftekhar; Kyungah Suh; Ashley G Woolfork; Susan Ovbude; Allegra Pekarek; Morgan Walters; Shae Lott; David S Hage
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2020-08-14       Impact factor: 3.205

Review 7.  Targeting Anti-Cancer Active Compounds: Affinity-Based Chromatographic Assays.

Authors:  Marcela Cristina de Moraes; Carmen Lucia Cardoso; Cláudia Seidl; Ruin Moaddel; Quezia Bezerra Cass
Journal:  Curr Pharm Des       Date:  2016       Impact factor: 3.116

8.  Recent Advances in Supramolecular Affinity Separations: Affinity Chromatography and Related Methods.

Authors:  Ashley G Woolfork; Sazia Iftekhar; Susan Ovbude; Kyungah Suh; Sadia Sharmeen; Isaac Kyei; Jacob Jones; David S Hage
Journal:  Adv Chromatogr       Date:  2021       Impact factor: 0.400

9.  Development and validation of quantitative structure-activity relationship models for compounds acting on serotoninergic receptors.

Authors:  Grażyna Zydek; Elżbieta Brzezińska
Journal:  ScientificWorldJournal       Date:  2012-04-24
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.